Therefore, we speculated that EPYC in ovarian cancer might regulate the expression of SNAI2 by activating the TGF-β/PI3K/AKT signaling pathway, and promoted the occurrence of EMT and invasion and metastasis of ovarian cancer. Here, EPYC is linked to ovarian carcinoma.